The EMA urges to adapt Covid-19 vaccines to the XFG variant for the 2026/2027 campaign
The European Medicines Agency's (EMA) Emergency Task Force (ETF) has proposed modifying the composition of COVID-19 vaccines so that they focus on the new XFG variant of SARS-CoV-2 in the upcoming 2026/2027 immunization campaign.The recommendation comes after the increase in XFG circulation worldwide since last June. This variant, integrated into...
5 minutos